- Home
- AEG vs AXSM Comparison
AEG vs AXSM Comparison
Compare AEG & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AEG | AXSM |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | Netherlands | United States |
| Employees | 15500 | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 9.0B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | AEG | AXSM |
|---|---|---|
| Price | $6.78 | $154.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 17 |
| Target Price | N/A | ★ $209.18 |
| AVG Volume (30 Days) | ★ 5.8M | 493.1K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 5.46% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $175.15 | $58.34 |
| Revenue Next Year | $1.22 | $54.30 |
| P/E Ratio | $7.91 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.42 | $86.99 |
| 52 Week High | $8.15 | $191.50 |
Technical Indicators
Market Signals| Indicator | AEG | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 30.77 | 31.90 |
| Support Level | N/A | $148.14 |
| Resistance Level | $8.02 | $191.13 |
| Average True Range (ATR) | 0.15 | 4.67 |
| MACD | -0.05 | -1.37 |
| Stochastic Oscillator | 0.00 | 9.19 |
Price Performance
Historical ComparisonAbout AEG Aegon Ltd. New York Registry Shares
Aegon is a life insurance and long-term savings business listed in the Netherlands. It was listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the company that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile earnings products and recycle funds into capital-light and more predictable strategic businesses.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.